乳腺癌围手术期中西医结合临床路径实施分析  

Analysis of clinical pathway implementation for breast cancer in perioperative period combined with traditional Chinese and Western medicine

作　　者：刘鹏熙[1] 李幸运[1] 钟少文[1] 陈前军[1] 林毅[1] 任黎萍[1] 王一安[1] 赖熙文[1] 朱华宇[1] 

机构地区：[1]广州中医药大学广东省中医院乳腺科,广州510405

出　　处：《岭南现代临床外科》2007年第5期350-353,共4页Lingnan Modern Clinics in Surgery

摘　　要：目的评估乳腺癌围手术期临床路径实施对住院日、住院费用及医疗质量的影响。方法制订乳腺癌围手术期中西医结合临床路径表,选择2004-2005年可手术的乳腺癌病人167例随机分为2组,临床路径组83例按路径表实施诊疗过程,对照组84例按传统方法完成治疗;同时筛选2003年符合临床路径纳入标准的病人74例,作为前后对照组,比较3组间的治疗效果。结果实施临床路径可降低住院费用(P<0.05),缩短住院天数(P<0.01),且3组间各项医疗质量指标均无差异(P>0.05)。结论乳腺癌临床路径可降低住院费用,缩短住院天数,确保医疗质量,值得推广应用。perioperative period list was established Western medicine. December 2005. 83 group were managed Objective To assess the effect of clinical pathway （CP）for breast cancer in on the cost and time of hospitalization and quality of medicine. Methods The CP for breast cancer in perioperative period combined with traditional Chinese and 167 operable patients were randomly divided into two groups from January 2004 to patients as CP group were managed on the clinical pathway. 84 patients as control according to traditional ways. At the same time, 74 patients who admitted for this study in 2003 were used as another control historical control. Outcomes were compared with the three groups of patients. Results There was a statistically significant reduction in the mean time of hospitalization （P〈0.01） and the mean cost per case （P〈0.05）, but no differences were in quality of medicine （P 〉0.05） after implementation of the clinical pathway. Conclusion Implementation of clinical pathway of breast cancer can reduce the cost of hospitalization, shorten the time of hospitalization and guarantee the quality of medicine.

关 键 词：乳腺癌 围手术期 中西医结合 临床路径 

分 类 号：R737.9[医药卫生—肿瘤]